Levine James E. Insider Trades

Insider Trading History

Track insider trading activity for Levine James E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $1.81M 1,295,117 shares
Last Trade
Mar 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 332,621 shares
$3.58
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $94.8k 67,716 shares
Last Trade
Dec 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12k 2,400 shares
$5.00
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $91.4k 65,316 shares
Last Trade
Dec 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.9k 2,752 shares
$5.42
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $87.6k 62,564 shares
Last Trade
Dec 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.82k 2,564 shares
$3.83
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $1.35M 962,496 shares
Last Trade
Mar 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 205,008 shares
$3.51
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $1.06M 757,488 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 197,472 shares
$1.72
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $84k 60,000 shares
Last Trade
Sep 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.8k 30,000 shares
$1.56
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $784k 560,016 shares
Last Trade
Mar 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 170,016 shares
$2.50
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $42k 30,000 shares
Last Trade
Sep 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.6k 5,000 shares
$6.32
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Chief Financial Officer
Holding Value $546k 390,000 shares
Last Trade
Jul 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.55M 390,000 shares
$6.55
$1.40
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $28.8M 130,000 shares
Last Trade
Mar 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.63M 130,000 shares
$51.00
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $11.1M 50,000 shares
Last Trade
Nov 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.99M 50,000 shares
$39.80
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $24.4M 110,000 shares
Last Trade
Mar 19, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.36M 110,000 shares
$39.60
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $13.7M 61,891 shares
Last Trade
Mar 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$990k 25,000 shares
$39.60
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 28, 2020 Sale (In The Money)Reported as In The Money on SEC Form 4.
$543k 6,891 shares
$78.80
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $46.9M 211,891 shares
Last Trade
Jan 28, 2020 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$543k 6,891 shares
$78.80
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $45.4M 205,000 shares
Last Trade
Sep 24, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.12M 30,000 shares
$37.40
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $6.64M 30,000 shares
Last Trade
Sep 24, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.12M 30,000 shares
$37.40
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Chief Financial Officer
Holding Value $38.7M 175,000 shares
Last Trade
Dec 03, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7M 175,000 shares
$72.40
$221.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up